氯吡格雷联合低分子肝素治疗不稳定心绞痛临床观察

Clinical Study of Clopidogrel and Low Molecular Weight Heparin in Treatment of Unstable Angina Patients.

目的探讨不稳定心绞痛(UA)的药物疗效,防止冠脉闭塞。方法选择近几年住院的UA患者分别作为治疗组(氯吡格雷+低分子肝素)和对照组(拜阿司匹林+香丹注射液)各40例,进行1周疗效对比。结果两组基础临床资料差异无统计学意义,治疗组临床症状缓解和心电图ST-T恢复较快。结论氯吡格雷联合低分子肝素可预防血栓形成,治疗UA患者效果较好。

Objective To evaluate the medicine curative effect about unstable angina therapy and prevent from coronary infarction. Methods A total of 80 UA patients in hospital recently years were divided into treated group（ Clopidogrel and Low molecular weight heparin） and control group（Aspirin and Xiangdan injection） witheach group 40 cases. Patients in Two group s were treated for a week and the curative effect was compared. Results There was no difference in baseline clinical data between two groups. Patients in The treated group were improved fast in clinical symptom and cardiogram ST -T segment. Conclusion Clopidogrel and Low molecular weight heparin can prevent from thrombus forming and have good effective in UA patients.